Indomethacin gel preparations made by dissolving the drug in Pluronic aqueous gels were administered rectally to rabbits and the drug plasma levels were determined. When indomethacin gel preparations with 20% (w/w) Pluronic F-127 were given to rabbits, the plasma concentration reached the maximum level 0.5 h after administration. On the other hand, the 25% (w/w) Pluronic F-127 gel preparation did not show a sharp peak of plasma concentration and produced a sustained-release effect. The 30% (w/w) gel preparation also gave a sustained-release effect, but it was not a desirable preparation because its [A U C]100 was only half that of a commercial suppository. Pluronic F-108 and Pluronic F-98 did not give a sustained-release effect at the concentration of 25% (w/w).
Preparation of Pluronic Gels All Pluronic formulations were prepared on a weight percentage basis by the cold process. An appropriate amount of Pluronic was slowly added to cold phosphate buffer at pH 7.2 in a vial containing a magnetic stirring bar with gentle mixing. The container was left overnight in a refrigerator to ensure complete dissolution. With time, a clear, viscous solution formed. Indomethacin was dissolved in each gel at a concentration of 0.8% (w/v).
Measurement of Drug Release from Pluronic Gels Indomethacin release rates were measured by using a plastic dialysis cell containing a membrane barrier (Visking Co., type 36/32).
2) The drug concentration of the sample was determined with a spectrophotometer at 266 nm. All experiments were carried out in triplicate and average values were plotted. Rectal Absorption White male rabbits weighing 3.3-3.8 kg were fasted for 36 h prior to the experiments but allowed free access to water. Pluronic gel preparation was administered into the rectum 3-5 cm above the anus through a stomach sonde needle for rats (KN-348, Natsume Seisakusho, Tokyo) fitted on a glass syringe: the gel was chilled prior to filling the syringe to facilitate this procedure. Indomethacin gel preparation was given as 3 ml of Pluronic gel containing 25 mg of the drug. At predetermined intervals, 1 ml of blood was collected from the ear vein and centrifuged at .3000 rpm for 10 min. The plasma concentration of indomethacin was determined chromatographically by the method of Skellern and Salole9) with slight modifications.8)
Morphological Studies on Rectal Tissue in Rats Male, Wistar rats weighing 200 g were fasted for 18 h prior to experiments but allowed free access to water. The Pluronic F-127 gel without drug (0.4 ml) was administered to the rat rectum. After 1 and 6 h, the rectum was isolated, rinsed with a saline solution, fixed in 10% formalin and cut into slices. The slices were stained with hematoxylin-eosin, and observed under a light microscope (model PM-10-A, Olympus, Tokyo).
Results

In Vitro Release Experiment
The effects of Pluronic F-127 concentration on the drug release kinetics are illustrated in other Pluronics at the concentration of 25% (w/w) (Fig. 3) ; the rates of release were F-98 = F-108 > F-127. This order seems to be the reverse of the order of viscosity of the gels at 37 C.10)
Plasma Concentrations of Indomethacin after Rectal Administration
The plasma levels of indomethacin after rectal administration of Pluronic F-127 gel preparation at various concentrations are shown in Fig. 4 . Table I summarizes the parameters of bioavailability, with the previous results8) using commercial indomethacin suppositories. 
Discussion
As a part of an investigation into the potential use of Pluronic F-127 gels as sustainedrelease depot preparations, we studied the in vitro and in vivo release characteristics of indomethacin from various gel formulations. In the in vitro release experiments, the effect of the gel concentration was evident; the higher the concentration of the gel, the slower indomethacin release was (Fig. 1) . As is evident from Fig. 4 , the results of in vivo absorption experiments at various concentrations coincide with the in vitro ones. That is, the 20% (w/w) Pluronic F-127 gel produced a sharp peak of plasma concentration and did not give a sustained-release effect. At higher concentrations (25 and 30% w/w), where drug release was slower, indomethacin absorption was also slower and the plasma level was maintained for longer. However, the 30% (w/w) gel preparation is not desirable, because its [A UC]° value was only half (56%) that of the commercial suppository, indicating that the extent of bioavailability was small. The 25% (w/w) Pluronic F-108 and Pluronic F-98 did not give a sustained-release effect (Fig. 5) . On the basis of the release experiments (Fig. 3 ), some differences in the blood levels after rectal administration of the F-98 or F-108 gels and the F-127 gel would be expected. However, the results obtained in this study indicate that there are no distinct differences in the blood levels. The low plasma levels of the F-98 or F-108 gels appear to be attributable to their higher osmotic pressure and/or greater hydrophilicity than the F-127 gels, but further work is.required to clarify this point.
The 25% (w/w) Pluronic F-127 gel preparation gave a plateau level of drug in the plasma after rectal administration without producing a sharp peak of plasma concentration. Therefore, it was considered that this Pluronic gel preparation is a suitable dosage form for reducing the incidence of side effects and the frequency of administration.
In particular, Pluronic F-127 is desirable because it has low toxicity. The toxicological properties of this series of block polymers have been studied, and the results indicate that Pluronic F-127 is one of the least toxic of commercially available block polymers.3) Although one must take into consideration the membrane damage due to some surfactants, which is undesirable, damage to the mucosal membrane by Pluronic F-127 was rarely found in rat rectum (Fig. 6) . Malik et al.11) reported that Pluronic F-68 has no effect on the membrane. In addition, the individual differences on rectal administration of the 25% (w/w) Pluronic F-127 gel preparation seemed to be small compared with those of other preparations.
These results suggest that indomethacin preparations based on Pluronic F-127 aqueous gel given by rectal administration may have clinical potential. There are several dosage forms available for the rectal delivery of drugs: suppositories, rectal gelatin capsules, and enemas.° Pluronic F-127 gel is potentially useful for sustained-drug release when given in the form of enemas.
Pluronic F-127 gel possess several properties which appear to be particularly suitable for the formulation of enema dosage forms. There is no practical difficulty in administration of the gel preparation, since the gelation is reversible, and this reversible sol-gel property allows a cool solution to flow into the rectum. Since it is water-soluble, Pluronic gel can be easily removed by washing in water.
The preparation of gels based on Pluronic F-127 is a very simple matter. One may use either a "cold" or a "hot" technique.3) Once the Pluronic is completely dissolved, ingredients may be added.
Another advantage of using Pluronic F-127 is its general applicability to most drugs; water-insoluble material become solubilized in the surfactant micelles (the Pluronic gels are known to contain a large population of micelles4,12)).
